Background Egypt has the highest prevalence of hepatitis C virus (HCV) in the world,
estimated nationally at 14.7%. Our study's objective was to delineate the evidence on the …

An estimated 8–10 million people suffer from viral hepatitis in Egypt. Hepatitis A virus (HAV)
and hepatitis E virus (HEV) are the major causes of viral hepatitis in Egypt as 50% or more of …

Background Hepatocellular carcinoma (HCC), or liver cancer, is the third leading cause of
cancer deaths worldwide, with prevalence 16–32 times higher in developing countries than …

Egypt has the highest prevalence of antibodies to hepatitis C virus (HCV) in the world,
estimated nationally at 14.7%. An estimated 9.8% are chronically infected. Numerous HCV …

Hepatitis B virus (HBV), a DNA virus with a human-only reservoir, is a worldwide public
health problem. Hepatitis B is transmitted through parenteral or mucosal exposure to …

Viral hepatitis B is a global public health problem affecting nearly two billion subjects; 3.3%
of whom are from the WHO (World Health Organization) Eastern Mediterranean Region …

Introduction: The epidemiology of viral hepatitis during pregnancy is of paramount
importance for health planners and program managers. Data on viral hepatitis during …

Results We included 66 eligible studies. The pooled prevalence of HBsAg in blood donors
of both EMRO and middle eastern (E and M) countries was 2.03%(95% confidence interval …

Infection with hepatitis B virus (HBV) remains a top health priority worldwide and a
devastating cause of morbidity and mortality accounting for more than 600,000 deaths in …

Background: Screening for hepatitis B virus surface antigen (HBsAg) reduces the risk of
transfusion‐transmitted hepatitis B viral (HBV) infection. However, the absence of HBsAg in …